Advisory Committee on Immunization Practices (ACIP), 29755 [2011-12563]
Download as PDF
<![CDATA[
29755
Federal Register / Vol. 76, No. 99 / Monday, May 23, 2011 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Number of responses per
respondent
Average burden
per response
Total burden
hours
CFR
Form name
73.19(a)(b) ......................................
180
1
1
180
320
9
1
2,880
73.5 & 73.6(d–e) .............................
73.3 & 73.4(e)(1) ............................
73.10(e) ...........................................
73.20 ...............................................
73.18 ...............................................
Notification of Theft, Loss or Release.
Report of Identification of Select
Agent.
Request of Exemption ....................
Request for Exclusions/Restricted
Request for Expedited Review .......
Administrative Review ....................
Inspections .....................................
3
71
1
30
320
1
1
1
1
1
1
1
1
4
8
3
71
1
120
2,560
Total .........................................
.........................................................
........................
........................
73.5 & 73.6(a)(b) ............................
Dated: May 17, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–12571 Filed 5–20–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
srobinson on DSK4SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned committee:
Time and Date
8 a.m.–6 p.m., June 22, 2011.
8 a.m.–4 p.m., June 23, 2011.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton
Road, NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited
only by the space available.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate uses of immunizing agents.
In addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines.
Matters To Be Discussed: The agenda
will include discussions on: human
papillomavirus vaccines, pertussis,
meningococcal vaccine, influenza,
VerDate Mar<15>2010
16:22 May 20, 2011
Jkt 223001
febrile seizures related to vaccine
administration, herpes zoster vaccine,
13-valent pneumococcal conjugate
vaccine (PCV13), new MMR Vaccine
Work Group, two dose varicella
vaccination and hepatitis B vaccine.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie B. Thomas, National Center
for Immunization and Respiratory
Diseases, CDC, 1600 Clifton Road, NE.,
(E–05), Atlanta, Georgia 30333,
Telephone: (404)639–8836, Fax:
(404)639–8905, E-mail: acip@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: May 16, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–12563 Filed 5–20–11; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Ethics
Subcommittee (ES)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIMES AND DATES:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
............................
8,878
1 p.m.–5 p.m., June 16, 2011
8:30 a.m.–12:30 p.m., June 17, 2011
PLACE: CDC, Thomas R. Harkin Global
Communications Center, Distance
Learning Auditorium, 1600 Clifton
Road, NE., Atlanta, Georgia 30333. This
meeting is also available by
teleconference. Please dial (877) 928–
1204 and enter code 4305992.
STATUS: Open to the public, limited only
by the space available. The meeting
room accommodates approximately 60
people. To accommodate public
participation in the meeting, a
conference telephone line will be
available. The public is welcome to
participate during the public comment.
The public comment periods are
tentatively scheduled from 4 p.m.–4:15
p.m. on June 16, 2011 and from 12
p.m.–12:15 p.m. on June 17, 2011.
PURPOSE: The ES will provide counsel
to the ACD, CDC, regarding a broad
range of public health ethics questions
and issues arising from programs,
scientists and practitioners.
MATTER TO BE DISCUSSED: Agenda items
will include the following: An update
on ES presentation during the April 28,
2011, ACD, CDC meeting; discussion of
next steps on addressing potential
public health ethical issues associated
with implementation of effective
preventive interventions for
noncommunicable disease; and review
of workgroup progress on developing
practical tools to assist state, tribal,
local, and territorial health departments
in their efforts to address public health
ethics challenges. The agenda is subject
to change as priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
For security reasons, members of the
public interested in attending the
meeting should contact Drue Barrett,
PhD, Designated Federal Officer, ACD,
CDC–ES, 1600 Clifton Road, NE., M/S
D–50, Atlanta, Georgia 30333.
Telephone (404) 639–4690. E-mail:
dbarrett@cdc.gov. The deadline for
E:\FR\FM\23MYN1.SGM
23MYN1
]]>Agencies
[Federal Register Volume 76, Number 99 (Monday, May 23, 2011)]
[Notices]
[Page 29755]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12563]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned committee:
Time and Date
8 a.m.-6 p.m., June 22, 2011.
8 a.m.-4 p.m., June 23, 2011.
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton
Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director, CDC,
on the appropriate uses of immunizing agents. In addition, under 42
U.S.C. 1396s, the committee is mandated to establish and periodically
review and, as appropriate, revise the list of vaccines for
administration to vaccine-eligible children through the Vaccines for
Children (VFC) program, along with schedules regarding the appropriate
periodicity, dosage, and contraindications applicable to the vaccines.
Matters To Be Discussed: The agenda will include discussions on:
human papillomavirus vaccines, pertussis, meningococcal vaccine,
influenza, febrile seizures related to vaccine administration, herpes
zoster vaccine, 13-valent pneumococcal conjugate vaccine (PCV13), new
MMR Vaccine Work Group, two dose varicella vaccination and hepatitis B
vaccine.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Stephanie B. Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E-05), Atlanta, Georgia 30333, Telephone: (404)639-8836,
Fax: (404)639-8905, E-mail: acip@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: May 16, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-12563 Filed 5-20-11; 8:45 am]
BILLING CODE 4160-18-P
